Data / Drug companies / Dextromethorphan hydrobromide
Dextromethorphan hydrobromide: 17 companies and 28 products in the FDA NDC directory
Dextromethorphan hydrobromide is listed in the FDA National Drug Code Directory by 17 companies, with 28 products in commercial distribution. 0 of the products (0.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are capsule, liquid filled; lozenge; tablet, and the newest product started marketing on October 1, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 17
- Products
- 28
- Generic (ANDA) products
- 0 (0.0%)
- Application numbers
- 2
- Routes
- Oral
- Brand names
- Mucinex Childrens Mighty Chews Cough, Quality Choice Adult Long-Acting Cough Softgel, Childrens Robitussin Cough Long-Acting, Mucinex Instasoothe Cough, Long Acting Cough Softgels, Cough Relief, Stona, BupropiDex
- openFDA record search
- api.fda.gov
Companies that list dextromethorphan hydrobromide
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Haleon US Holdings LLC | 4 | capsule, liquid filled; liquid | Over the counter monograph drugs | June 19, 2024 |
| Cabinet Health P.B.C. | 3 | capsule, liquid filled; capsule, gelatin coated | Over the counter monograph drugs | February 1, 2026 |
| Reckitt Benckiser LLC | 3 | tablet, chewable; lozenge | Over the counter monograph drugs | June 3, 2024 |
| CVS Woonsocket Prescription Center, Incorporated | 2 | capsule, liquid filled | Over the counter monograph drugs | February 2, 2024 |
| Chain Drug Marketing Association, Inc. | 2 | capsule, liquid filled | Over the counter monograph drugs | September 9, 2026 |
| DXM Pharmacuetical, Inc. | 2 | tablet | Over the counter monograph drugs | September 10, 2024 |
| Socius Care, LLC | 2 | syrup | Over the counter monograph drugs | August 11, 2016 |
| Advanced Rx LLC | 1 | capsule, liquid filled | Over the counter monograph drugs | January 1, 2025 |
| AptaPharma Inc. | 1 | liquid | Over the counter monograph drugs | September 30, 2020 |
| Glenmark Therapeutics Inc., USA | 1 | capsule, liquid filled | Over the counter monograph drugs | October 1, 2026 |
| Meijer Distribution Inc | 1 | lozenge | Over the counter monograph drugs | April 12, 2016 |
| Nuvicare LLC | 1 | capsule, liquid filled | Over the counter monograph drugs | March 24, 2026 |
| Pioneer Life Sciences, LLC | 1 | capsule, liquid filled | Over the counter monograph drugs | March 24, 2026 |
| Rugby Laboratories | 1 | capsule, liquid filled | Over the counter monograph drugs | May 8, 2026 |
| Sato Pharmaceutical Co., Ltd. | 1 | lozenge | Over the counter monograph drugs | November 19, 1995 |
| Softgel Healthcare Pvt Ltd | 1 | capsule, liquid filled | Over the counter monograph drugs | September 11, 2024 |
| Strive Pharmaceuticals Inc. | 1 | capsule | Over the counter monograph drugs | April 1, 2022 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Capsule, liquid filled | 14 | 50% |
| Lozenge | 3 | 10.7% |
| Tablet | 3 | 10.7% |
| Tablet, chewable | 2 | 7.1% |
| Liquid | 2 | 7.1% |
| Syrup | 2 | 7.1% |
| Capsule, gelatin coated | 1 | 3.6% |
| Capsule | 1 | 3.6% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 28 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Sigma-1 Agonist | 28 |
| Uncompetitive N-methyl-D-aspartate Receptor Antagonist | 28 |
| Standardized Chemical Allergen | 1 |
| Expectorant | 1 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.